IN2014CH00518A - - Google Patents

Download PDF

Info

Publication number
IN2014CH00518A
IN2014CH00518A IN518CH2014A IN2014CH00518A IN 2014CH00518 A IN2014CH00518 A IN 2014CH00518A IN 518CH2014 A IN518CH2014 A IN 518CH2014A IN 2014CH00518 A IN2014CH00518 A IN 2014CH00518A
Authority
IN
India
Prior art keywords
formula
compound
bzo
deoxy
fluoro
Prior art date
Application number
Other languages
English (en)
Inventor
Thirumalai Rajan Srinivasan
Kishore Kumar Muppa
Srinivas Rao Nimmala
Original Assignee
Msn Lab Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Private Ltd filed Critical Msn Lab Private Ltd
Priority to IN518CH2014 priority Critical patent/IN2014CH00518A/en
Priority to PCT/IN2015/000068 priority patent/WO2015118558A2/en
Publication of IN2014CH00518A publication Critical patent/IN2014CH00518A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
IN518CH2014 2014-02-04 2015-02-04 IN2014CH00518A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN518CH2014 IN2014CH00518A (de) 2014-02-04 2015-02-04
PCT/IN2015/000068 WO2015118558A2 (en) 2014-02-04 2015-02-04 Process for the preparation of clofarabine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN518CH2014 IN2014CH00518A (de) 2014-02-04 2015-02-04

Publications (1)

Publication Number Publication Date
IN2014CH00518A true IN2014CH00518A (de) 2015-08-07

Family

ID=53778571

Family Applications (1)

Application Number Title Priority Date Filing Date
IN518CH2014 IN2014CH00518A (de) 2014-02-04 2015-02-04

Country Status (2)

Country Link
IN (1) IN2014CH00518A (de)
WO (1) WO2015118558A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105601688A (zh) * 2015-12-23 2016-05-25 国药一心制药有限公司 一种氯法拉滨中间体及氯法拉滨的制备方法
CN106397518B (zh) * 2016-10-18 2019-05-17 武汉百科药物开发有限公司 一种氯法拉滨的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3851601A (en) * 2000-02-18 2001-08-27 Southern Res Inst Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-9h- purin-6-amine
US6680382B2 (en) * 2001-08-02 2004-01-20 Ilex Products, Inc. Process for preparing purine nucleosides
CN101555267A (zh) * 2008-04-09 2009-10-14 杭州容立医药科技有限公司 一种核苷酸类似物克罗拉滨的合成方法
CN101265284B (zh) * 2008-05-07 2011-04-27 深圳万乐药业有限公司 氯法拉滨的合成方法

Also Published As

Publication number Publication date
WO2015118558A3 (en) 2015-11-05
WO2015118558A2 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
MX2022015612A (es) Nucleotidos de purina beta-d-2'-desoxi-2'-alfa-fluoro-2'-beta-c-su stituidos-2-modificados-n6-sustituidos para el tratamiento del virus de la hepatitis c.
PH12018500856A1 (en) Respiratory syncytial virus vaccine
EP4424835A3 (de) Zusammensetzungen und verfahren zur synthese von 5'-verkappten rnas
WO2017070626A3 (en) Respiratory virus vaccines
GEP201706793B (en) Substituted nucleosides, nucleotides and analogs thereof
AR108263A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
BR112014011340A2 (pt) métodos para a preparação de análogos de nucleotídeos antivirais
BR112013018975A2 (pt) processo para o preparo de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos
HK1245800A1 (zh) 被取代的核苷、核苷酸及其类似物
HK1224229A1 (zh) 取代的核苷,核苷酸及其类似物
MY197236A (en) 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
MX2018007955A (es) Proceso de preparacion de agonistas c de guanilato cliclasa.
MX2017010195A (es) Sal de un compuesto de pirimido [6,1-a]isoquinolin-4-ona.
EA034882B9 (ru) Способ синтеза полинуклеотида
BR112017020380A2 (pt) processo para separar hidrocarbonetos de uma solução compreendendo um polímero
Uneyama et al. Toward nucleophilic trifluoroethylation: generation, stabilization and alkylation of 1-substituted and 1, 1-disubstituted 2, 2, 2-trifluoroethyl carbanion equivalents
IN2014CH00518A (de)
WO2016166720A3 (en) Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
ZA202405277B (en) Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
PH12016501808A1 (en) Chemical compounds
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
WO2016059646A3 (en) Improved process for the preparation of 4- [6-amino-5-bromo-2- [(4-cvanophenyl) aminol]-4-pvrimidinvl]oxv]-3.5-dimethvlbenzonitrile
CL2011000717A1 (es) Compuesto derivado de fosforamidato de nucleosido de purina, un hidrato o solvato del mismo; composicion que lo comprende; proceso de preparacion, util para el tratamiento de la infeccion por el virus de la hepatitis c (vhc).
BR112017027815A2 (pt) método para a produção de ácido 2,4-dihidroxibutírico